Navigation Links
Vein-Opening Treatment for MS Stirs Controversy
Date:1/18/2011

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, Jan. 18 (HealthDay News) -- Preliminary research and reports from patients suggest that a controversial treatment for multiple sclerosis can help relieve fatigue and other symptoms, but many physicians remain highly skeptical of the claims.

The debate started in 2009, when Dr. Paolo Zamboni, a vascular surgeon from Italy, published an intriguing study that suggested that a blockage in the veins that drain blood from the brain and spinal cord and return it to the heart might contribute to multiple sclerosis (MS).

Calling it chronic cerebrospinal venous insufficiency, or CCSVI, Zamboni's theory was that the blockages disrupt the flow of blood from the brain and spinal cord, causing blood to back up and damage the brain and the spinal cord.

Zamboni began surgically treating people with MS with balloon angioplasty to open their veins. Other CCSVI researchers have tried stents, in which a wire mesh is placed in the vein to prop it open.

The methods of Zamboni and the others set off a heated debate among physicians and patients. Many MS physicians consider the claims utter hooey. But many people with MS, desperate for relief, pressed for research, and some, unwilling to wait, sought out physicians abroad who'd do the surgery.

Despite the skepticism, U.S. researchers began investigating venous blockage. In June, the National Multiple Sclerosis Society announced $2.4 million in funding for CCSVI studies, most of which are trying to answer the basic question of whether there is actually a link between venous blockages and MS.

Among those conducting CCSVI research is Dr. Michael Dake, a professor of cardiothoracic surgery at Stanford University School of Medicine.

Dake followed 30 people with MS who had stents implanted to open their veins. Two months after surgery, they reported feeling 50 percent less fatigued than before surgery, Dake said. They co
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Chaperone enzyme provides new target for cancer treatments
2. Adolescents with severe mental disorders have never received treatment
3. Some Severe MS Flares Helped by Blood Filtering Treatment
4. International research team reports major findings in prevention and treatment of blood clots
5. Routine blood test may identify people with pre-diabetes, cutting later treatment costs
6. IDSA announces first guidelines for treatment of MRSA infections
7. Study Gauges Best Treatments for Chronic Pelvic Pain in Men
8. ATS issues statement on the treatment of pulmonary fungal infections
9. Team-Based Treatment Helps Those With Cluster of Chronic Illnesses
10. Drug Abuse Treatment Rates on the Rise: U.S. Report
11. Case Western Reserve receives $10M to study retinal disease, develop new treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vein-Opening Treatment for MS Stirs Controversy
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
(Date:5/29/2015)... 2015 The Global Allopurinol Industry ... on the current state of the Allopurinol industry.With ... statistics on the state of the industry and ... for companies and individuals interested in the market. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/29/2015)... May 29, 2015 Designed with the ... up to create an all new, exclusive line of ... formulated with the latest and greatest, high impact, result ... to be effective. The 24/7 Series can be used ... and even the casual fitness enthusiasts. There are no ...
(Date:5/29/2015)... 29, 2015 Javlin continues to fulfill ... headquarters and a larger team, with the intention to ... market share in the U.S. and Canada. , Javlin ... achieved significant growth in 2014 with its strongest earnings ... data integration platform, CloverETL. To accelerate further progress and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 This ... current state of the Naproxen industry.The report provides ... classifications, applications and industry chain structure. The ... international markets including development trends, competitive landscape analysis, ... are discussed as well as manufacturing processes and ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
... Group Upgrades from Allscripts Document Management; Expects ... Break-Even on Clinical & Financial Investment, CHICAGO ... leading provider of clinical software, connectivity and,information solutions ... The Heart Center Medical Group has selected the ...
... Medicare Fraud Strike Force, WASHINGTON, April 30 ... late yesterday of Medicare fraud,Assistant Attorney General Alice S. ... Acosta of the Southern District of Florida,announced today., ... Caos, 62, guilty on all,charged counts, including: conspiracy to ...
... PARK, Ohio, April 30 "Opportunities for,Next-Generation ... Medical,Devices Conference, will bring together the diverse ... cardiovascular, orthopaedic,neurological and pulmonary applications., Hosted ... world,s leading,materials society, this unique forum will ...
... Idiopathic pulmonary fibrosis (IPF) patients learn from specialists,seek ... The following announcement,was released by The Coalition ... Free Educational Seminar for Patients and Their,Families, ... with The,Coalition for Pulmonary Fibrosis (CPF), is hosting ...
... Pa., April 30 West Pharmaceutical,Services, Inc., (NYSE: ... 2008,Annual Meeting of Shareholders. The meeting will be held ... The live webcast can be accessed through the ... Please allow extra time prior,to the live webcast to ...
... for all holders of a valid press card / formal ... press facilities, including a working room, and the press office ... relevant experts. , You can register for ... direct any queries to the EULAR Press Office on ...
Cached Medicine News:Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 2Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 4Health News:Miami Jury Convicts Dermatologist of Medicare Fraud 2Health News:Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 3Health News:West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast 2
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) announced today ... for up to $1.6 billion aggregate principal amount of certain ... who tendered, and did not validly withdraw, their notes on ... time, on May 27, 2015 (the early tender date), ... to receive the total consideration. The total consideration for each ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... ) has announced the addition of Jain ... and Companies"  to their offering.  ... interference (RNAi) or gene silencing involves the ... inside the cell, this material is processed ...
(Date:5/28/2015)... May 28, 2015 AlloSource ®, ... cellular, bone, skin and soft-tissue allografts for use ... patient healing, today announced that AlloWrap® DS, its ... to the high-cost reimbursement category. ... and their patients," said Kimberly French , ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... WEBSTER, Texas, Nov. 10, 2011 IDEV Technologies, Incorporated ... for the company,s 6 French (6Fr) SUPERA VERITAS Transhepatic ... for sale outside the U.S. earlier this year, is ... the unique SUPERA stent, currently cleared in the U.S. ...
... Vascular Designs, Inc., a medical device manufacturing company, today ... FDA marketing clearance in 2009 – is now in ... in the treatment of liver cancer. The IsoFlow™ Infusion ... target and isolate areas within the body where the ...
Cached Medicine Technology:IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System 2Breakthrough Cancer Treatment Now in Use at UC Davis Medical Center 2
Medium....
Goldman single hook....
These products are supplied non-sterile and must be sterilized before use. For insertion through the smokevac and nezhat-dorsey trumpet valve in conjunction with the universal instrument insert adapt...
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
Medicine Products: